Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
All >

News > Western Europe

Please find below news about Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, the Netherlands and Switzerland as well as about organisations from these countries.

Total search results: 4094 | Ordered by Date (descending)
1 2 3 ... 39 40 41  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Oxford Biomedica plc. (7/17/24). "Press Release: Oxford Biomedica Announces Chief Financial Officer Transition. Lucinda Crabtree to Join as Chief Financial Officer". Basel. 2024-07-17
IZB Martinsried. (7/17/24). "Press Release: Life Science Pitch Day at the IZB. Innovations meet Investors". Martinsried. 2024-07-17
Nouscom AG. (7/17/24). "Press Release: Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development". Basel. 2024-07-17
Full-Life Technologies. (7/17/24). "Press Release: Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors". Heidelberg & Seoul. 2024-07-17
Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. 2024-07-16
Corden Pharma International GmbH. (7/16/24). "Press Release: CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe". Basel. 2024-07-16
Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. 2024-07-16
Affluent Medical S.A.. (7/12/24). "Press Release: Affluent Medical Signs Agreements for Mitral Valve Technologies with EUR 15M Upfront Payment". Rotterdam. 2024-07-12
Bioptimus SAS. (7/11/24). "Press Release: Bioptimus Launches H-optimus-0, the World’s Largest Open-source AI Foundation Model for Pathology". 2024-07-11
Pan Cancer T B.V.. (7/11/24). "Press Release: Pan Cancer T Secures EUR 4.25 Million in Seed Extension Round to Advance Next-generation T Cell Therapies". Rotterdam. 2024-07-11
Ipsen S.A.. (7/11/24). "Press Release: Ipsen and Foreseen Biotechnology Announce Exclusive Global Licensing Agreement for Antibody-Drug Conjugate with First-in-Class Potential". Paris. 2024-07-11
eTheRNA Immunotherapeutics N.V.. (7/10/24). "Press Release: Antonin (Tony) de Fougerolles Appointed as New Chair of Etherna". Niel. 2024-07-10
HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. 2024-07-10
Diadem S.p.A.. (7/10/24). "Press Release: Diadem Appoints Michael Rasche as Chief Executive Officer". Milan. 2024-07-10
Merz Therapeutics GmbH. (7/10/24). "Press Release: Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics". Frankfurt a. M.. 2024-07-10
SciRhom GmbH. (7/9/24). "Press Release: SciRhom Announces Approval of First Clinical Trial Application for a Novel iRhom2-targeting Antibody Against Autoimmune Diseases". Munich. 2024-07-09
Endoron Medical Ltd.. (7/9/24). "Press Release: Endoron Medical Raises $10 Million in Series A Funding Led by Sofinnova Partners to Accelerate the Validation of Its AAA EndoStapling Solution Aortoseal". Tel Aviv. 2024-07-09
SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. 2024-07-09
Biovance Capital Partners. (7/9/24). "Press Release: Biovance Capital Partners Announces First Closing of Its New Biotech Fund at €51 million". Lisbon. 2024-07-09
BioRN Cluster Management GmbH. (7/8/24). "Press Release: Advancing Personalised Medicine in Europe. BioRN Is Part of the Renowned EU Research Project PRECISEU". Heidelberg. 2024-07-08
Apeiron Biologics AG. (7/8/24). "Press Release: Apeiron Biologics to Be Acquired by Ligand Pharmaceuticals for USD 100 Million". Vienna. 2024-07-08
Evotec SE. (7/8/24). "Press Release: Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz". Hamburg & Seattle, WA. 2024-07-08
Anacura. (7/4/24). "Press Release: Anacura Acquires, Adding Multi-omics for Drug Discovery and Diagnostics to Its Services". Ghent. 2024-07-04
CureVac N.V.. (7/3/24). "Press Release: GSK and CureVac to Restructure Collaboration into New Licensing Agreement". London, Tübingen & Boston, MA. 2024-07-03
CureVac N.V.. (7/3/24). "Press Release: CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities". Tübingen & Boston, MA. 2024-07-03
Beacon Therapeutics Holdings Ltd.. (7/3/24). "Press Release: Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies". London & Cambridge, MA. 2024-07-03
Full-Life Technologies. (7/3/24). "Press Release: Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer". Heidelberg. 2024-07-03
Pentixapharm AG. (7/3/24). "Press Release: Pentixapharm Acquires Target Discovery Business of Glycotope". Würzburg & Berlin. 2024-07-03
Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert. 2024-07-03
Touchlight Genetics Ltd.. (7/2/24). "Press Release: Touchlight and LenioBio Collaborate to Accelerate Development of Protein Therapeutics for Pandemic Response". Hampton & Düsseldorf. 2024-07-02
Bruker Corporation. (7/2/24). "Press Release: Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin". Berlin. 2024-07-02
Heidelberg Epignostix GmbH. (7/2/24). "Press Release: DKFZ Spin-off Epignostix Raises €4.3m Seed Round to Commercialize Diagnostic Tumor Classifier". Heidelberg. 2024-07-02
Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen. 2024-07-02
Haya Therapeutics SA. (7/1/24). "Press Release: Haya Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award". Lausanne & San Diego, CA. 2024-07-01
Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. 2024-07-01
Partners Group AG. (7/1/24). "Press Release: Partners Group to Acquire Majority Stake in FairJourney Biologics, a Leading Antibody Discovery Contract Research Organization". Baar ZG. 2024-07-01
Idorsia Ltd.. (7/1/24). "Press Release: Idorsia’s Jeraygo (aprocitentan) Approved in Europe as First and Only ERA for the Treatment of Resistant Hypertension". Allschwil. 2024-07-01
Evotec SE. (6/25/24). "Press Release: Just – Evotec Biologics Selected by U.S. Department of Defense for Manufacturing Optimization Program". Hamburg. 2024-06-25
NLC Ventures Netherlands B.V.. (6/24/24). "Press Release: NLC Health Ventures Launches New Early-stage Drug Delivery Company". 2024-06-24
Allecra Therapeutics GmbH. (6/24/24). "Press Release: Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic Exblifeb in Gulf Cooperation Council countries and South Africa". Saint-Louis, Weil am Rhein 2024-06-24
Merck KGaA. (6/24/24). "Press Release: Merck Provides Update on Xevinapant Program in Locally Advanced Head and Neck Cancer [ Not intended for UK-, US- or Canada-based media ]". Darmstadt. 2024-06-24
Tecan Group Ltd.. (6/24/24). "Press Release: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division". Männedorf. 2024-06-24
BioNTech SE. (6/24/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer". Mainz & Shanghai. 2024-06-24
InflaRx N.V.. (6/24/24). "Press Release: InflaRx’s Gohibic (vilobelimab) Selected for First BARDA-sponsored Clinical Trial to Evaluate Novel Host-directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)". Jena. 2024-06-24
Charité – Universitätsmedizin Berlin. (6/21/24). "Press Release: Together for Innovation. Charité and Bayer Establish Berlin Center for Gene and Cell Therapies". 2024-06-21
High-Tech Gründerfonds Management GmbH. (6/20/24). "Press Release: Health Tech Start-up Carelane Raises €800,000 in Pre-Seed Funding to Revolutionize Clinical Trial Software". 2024-06-20
Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam. 2024-06-20
iOnctura B.V.. (6/20/24). "Press Release: iOnctura Announces EUR80 Million Series B Financing to Progress Pipeline through Phase II Trials". Geneva & Amsterdam. 2024-06-20
ITM Isotope Technologies Munich SE. (6/20/24). "Press Release: ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth". Garching. 2024-06-20
Wacker Chemie AG. (6/19/24). "Press Release: Wacker & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification". Munich, Halle (Saale) & Basel. 2024-06-19
Ethris GmbH. (6/18/24). "Press Release: Cipla EU to Invest an Additional EUR 3 Million in Ethris". Mumbai & Munich. 2024-06-18
Forbion Capital Partners. (6/18/24). "Press Release: Forbion Co-leads $190 Million Financing of Marea Therapeutics". Naarden. 2024-06-18
Sidekick Health. (6/18/24). "Press Release: Sidekick Health Expands Oncology and Women's Health Portfolio with Acquisition of PINK! in Germany". Amsterdam. 2024-06-18
Traceless Materials GmbH. (6/18/24). "Press Release: Female-founded Bioeconomy Start-up Traceless Partners with Mondi to Scale Natural, Regenerative Solutions in Paper Coating". Hamburg. 2024-06-18
Santhera Pharmaceuticals Holding AG. (6/18/24). "Press Release: Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even (Ad hoc announcement pursuant to Art. 53 LR)". Pratteln. 2024-06-18
NXI Therapeutics AG. (6/18/24). "Press Release: NXI Therapeutics Extends Pre-Seed Financing to CHF 3.5 Million in Run-up to Larger Seed Financing". Basel. 2024-06-18
Ethris GmbH. (6/18/24). "Press Release: Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Stud". Munich. 2024-06-18
Berlin Institute of Health. (6/12/24). "Press Release: New Perspectives for Patients. National Strategy for Gene and Cell Therapies Presented to the BMBF". 2024-06-12
High-Tech Gründerfonds Management GmbH. (6/12/24). "Press Release: New component for Germany’s Future Fund – HTGF Opportunity Fund Launches with €660 Million for Growth-phase Investments". 2024-06-12
Evotec SE. (6/12/24). "Press Release: Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb". Hamburg. 2024-06-12
Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA. 2024-06-11
Tacalyx GmbH. (6/11/24). "Press Release: Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs". Berlin. 2024-06-11
Thermosome GmbH. (6/11/24). "Press Release: Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer". Munich. 2024-06-11
Adcytherix SAS. (6/11/24). "Press Release: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates". Marseille. 2024-06-11
Ipsen S.A.. (6/10/24). "Press Release: Ipsen’s Iqirvo Receives U.S. FDA Accelerated Approval as a First-in-Class PPAR Treatment for Primary Biliary Cholangitis". Paris. 2024-06-10
Evotec SE. (6/10/24). "Press Release: Results of the Annual General Meeting 2024". Hamburg. 2024-06-10
MorphoSys AG. (6/6/24). "Press Release: Arkadius Pichota and Lukas Gilgen Appointed to Management Board of MorphoSys AG Replacing the Current CEO and CFO (Ad hoc)". Planegg. 2024-06-06
ITM Isotope Technologies Munich SE. (6/6/24). "Press Release: ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing". Garching. 2024-06-06
Seres Therapeutics, Inc.. (6/6/24). "Press Release: Seres Therapeutics Enters into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science". Cambridge, MA. 2024-06-06
Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna. 2024-06-04
Annogen B.V.. (6/4/24). "Press Release: Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters". Amsterdam. 2024-06-04
BenevolentAI S.A.. (6/4/24). "Press Release: BenevolentAI to participate in Goldman Sachs 45th Annual Global Healthcare Conference". 2024-06-04
PhoreMost Ltd.. (6/3/24). "Press Release: PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim". Cambridge. 2024-06-03
Wacker Chemie AG. (6/3/24). "Press Release: Wacker Opens mRNA Competence Center in Halle an der Saale, Germany". Munich & Halle (Saale). 2024-06-03
Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. 2024-06-03
Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo. 2024-06-03
NLC Ventures Netherlands B.V.. (6/3/24). "Press Release: Dutch Health Insurer VGZ Invests €6 Million in NLC Health Ventures". 2024-06-03
University of Frankfurt. (6/3/24). "Press Release: Goethe University Frankfurt Founds Institute for Digital Medicine". 2024-06-03
Nyxoah S.A.. (5/31/24). "Press Release: Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares". Mont-Saint-Guibert. 2024-05-31
Adaptimmune Therapeutics plc. (5/30/24). "Press Release: Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future 2024-05-30
Evotec SE. (5/30/23). "Press Release: Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases". Hamburg. 2024-05-30
High-Tech Gründerfonds Management GmbH. (5/30/24). "Press Release: Unlocking Soil Carbon. Berlin-based Climate Tech Startup Seqana Raises €2.1M Seed Round to Unlock Scalable Carbon Farming on 6 Continents from Space". Berlin. 2024-05-30
BRAIN Biotech AG. (5/29/24). "Press Release: BRAIN Biotech AG Announces the Appointment of Erik de Vries as Senior Business Development Director Enzymes". Zwingenberg & Greifswald. 2024-05-29
Merck KGaA. (5/29/24). "Press Release: Merck Signs MoU with KAIST to Advance Scientific Collaboration". Darmstadt. 2024-05-29
ProBioGen AG. (5/29/24). "Press Release: ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development". Berlin. 2024-05-29
ExpressionEdits Ltd.. (5/29/24). "Press Release: ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology". Cambridge. 2024-05-29
Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board". 2024-05-29
TVM Capital Healthcare. (5/28/24). "Press Release: TVM Capital Healthcare Announces the Closing of Its Saudi Arabia-Focused TVM Healthcare Afiyah Fund ". Riyadh. 2024-05-28
Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H 2024-05-28
CureVac N.V.. (5/28/24). "Press Release: CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK". Tübingen & Boston, MA. 2024-05-28
Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. 2024-05-28
Eisbach Bio GmbH. (5/24/24). "Press Release: Eisbach Bio Announces Successful Completion of Phase I Clinical Trial of Nucleic Acid Helicase Inhibitor EIS-10700 with Excellent Safety Properties". Martinsried. 2024-05-24
Boehringer Ingelheim. (5/22/24). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Expand Collaboration to Develop First-in-class Treatments for Cancer and Cardio-renal-metabolic Diseases". Ingelheim & Nantes. 2024-05-22
En Carta Diaganostics. (5/22/24). "Press Release: En Carta Diagnostics Secures €1.5m in Pre-seed Funding to Advance Diagnostic Kit Platform for Lyme disease". Paris. 2024-05-22
SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel. 2024-05-22
Deepull Diagnostics S.L.. (5/22/24). "Press Release: Deepull Appoints Didier Deltort to Its Board of Directors". Barcelona. 2024-05-22
Merck KGaA. (5/22/24). "Press Release: Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million". Darmstadt. 2024-05-22
Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford. 2024-05-22
BioNTech SE. (5/22/24). "Press Release: BioNTech to Evaluate NanoTag’s Target Labeling System in Different Therapeutic Areas". Mainz & Göttingen. 2024-05-22
Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris. 2024-05-22
1 2 3 ... 39 40 41  next pagenext page


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top